Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discussion of current and emerging therapies for neuroendocrine prostate cancer

July 26, 2022
Busola Alabi, PhD

The Stoyanova Lab publishes a review that examines various upcoming therapeutic strategies for neuroendocrine prostate cancer. Congratulations Busola and team!

https://www.sciencedirect.com/science/article/pii/S0163725822001498?via%3Dihub

July 26, 2022

NewsStanford

FacebookTwitterPinterestRedditDeliciousWhatsappEmail
  • PreviousExciting news: Dr. Alifiani Hartono joins the Stoyanova lab!

  • NextExciting news: Mark Buckup accepted into joint MD PhD Program at the University of California, San Diego

Related Posts ...

Dr. Shiqin Liu

Exciting News: Dr. Shiqin (Laura) Liu Receives Eula and Donald S. Coffey Innovative Research Award

News, UCLA

Exciting News: Dr. Alifiani Bonita Hartono wins Second Place at the UCLA Molecular and Medical Pharmacology Departmental Retreat

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login